174
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Ursodeoxycholic Acid Protects Colon Cancer HCT116 Cells From Deoxycholic Acid-Induced Apoptosis by Inhibiting Apoptosome Formation

, , , , &
Pages 617-626 | Received 13 Sep 2011, Accepted 22 Feb 2012, Published online: 12 Apr 2012

REFERENCES

  • Faubion , W A , Guicciardi , M E , Miyoshi , H , Bronk , S F Roberts , P J . 1999 . Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas . J Clin Invest , 103 : 137 – 145 .
  • Sodeman , T , Bronk , S F , Roberts , P J , Miyoshi , H and Gores , G J . 2000 . Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas . Am J Physiol Gastrointest Liver Physiol , 278 : G992 – G999 .
  • Yui , S , Kanamoto , R , Iwami , K and Saeki , T . 2007 . Taurocholic acid does not induce apoptosis in HCT116 cells regardless of its intracellular concentration . Biosci Biotechnol Biochem , 71 : 800 – 802 .
  • Higuchi , H , Grambihler , A , Canbay , A , Bronk , S F and Gores , G J . 2004 . Bile acids upregulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1 . J Biol Chem , 279 : 51 – 60 .
  • Schlottman , K , Wachs , F P , Krieg , R C , Kullmann , F Scholmerich , J . 2000 . Characterization of bile salt-induced apoptosis in colon cancer cell lines . Cancer Res , 60 : 4270 – 4276 .
  • Wachs , F P , Krieg , R C , Rodrigues , C M , Messmann , H Kullmann , F . 2005 . Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor . Int J Colorectal Dis , 20 : 103 – 113 .
  • Yui , S , Saeki , T , Kanamoto , R and Iwami , K . 2005 . Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid . J Biochem , 138 : 151 – 157 .
  • Yui , S , Kanamoto , R and Saeki , T . 2009 . Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells . Nutr Cancer , 61 : 374 – 380 .
  • Rodrigues , C M , Fan , G , Ma , X , Kren , B T and Steer , C J . 1998 . A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation . J Clin Invest , 101 : 2790 – 2799 .
  • Rodrigues , C M , Fan , G , Wong , P Y , Kren , B T and Steer , C J . 1998 . Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production . Mol Med , 4 : 165 – 178 .
  • Amaral , J D , Castro , R E , Sola , S , Steer , C J and Rodrigues , C M . 2007 . p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis . J Biol Chem , 282 : 34250 – 34259 .
  • Solá , S , Ma , X , Castro , R E , Kren , B T Steer , C J . 2003 . Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes . J Biol Chem , 278 : 48831 – 48838 .
  • Im , E and Martinez , J D . 2004 . Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells . J Nutr , 134 : 483 – 486 .
  • Im , E , Akare , S , Powell , A and Martinez , J D . 2005 . Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling . Nutr Cancer , 51 : 110 – 116 .
  • Holzinger , F , Schteingart , C D , Ton-Nu , H T , Eming , S A Monte , M J . 1997 . Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat . Hepatology , 26 : 1263 – 1271 .
  • Eckelman , B P , Salvesen , G S and Scott , F L . 2006 . Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family . EMBO Rep , 7 : 988 – 994 .
  • Allan , L A and Clarke , P R . 2007 . Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis . Mol Cell , 26 : 301 – 310 .
  • Allan , L A , Morrice , N , Brady , S , Magee , G Pathak , S . 2003 . Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK . Nat Cell Biol , 5 : 647 – 654 .
  • Seifert , A , Allan , L A and Clarke , P R . 2008 . DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine . FEBS J , 275 : 6268 – 6280 .
  • Seifert , A and Clarke , P R . 2009 . p38alpha- and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress . Cell Signal , 21 : 1626 – 1633 .
  • Azzaroli , F , Mehal , W , Soroka , C J , Wang , L Lee , J . 2002 . Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes . Hepatology , 36 : 49 – 54 .
  • Iwaki , T , Ishizaki , K , Kinoshita , S , Tanaka , H Fukunari , A . 2007 . Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters . World J Gastroenterol , 13 : 5003 – 5008 .
  • Rodrigues , C M , Ma , X , Linehan-Stieers , C , Fan , G Kren , B T . 1999 . Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation . Cell Death Differ , 6 : 842 – 854 .
  • Schoemaker , M H , Conde de la Rosa , L , Buist-Homan , M , Vrenken , T E Havinga , R . 2004 . Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways . Hepatology , 39 : 1563 – 1573 .
  • Solá , S , Amaral , J D , Borralho , P M , Ramalho , R M Castro , R E . 2006 . Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis . Mol Endocrinol , 20 : 2292 – 2303 .
  • Martinez , J D , Stratagoules , E D , LaRue , J M , Powell , A A Gause , P R . 1998 . Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation . Nutr Cancer , 31 : 111 – 118 .
  • Powell , A A , LaRue , J M , Batta , A K and Martinez , J D . 2001 . Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells . Biochem J , 356 : 481 – 486 .
  • Cardone , M H , Roy , N , Stennicke , H R , Salvesen , G S Franke , T F . 1998 . Regulation of cell death protease caspase-9 by phosphorylation . Science , 282 : 1318 – 1321 .
  • Rajesh , K G , Suzuki , R , Maeda , H , Yamamoto , M Yutong , X . 2005 . Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway . J Mol Cell Cardiol , 39 : 766 – 776 .
  • Rust , C , Bauchmuller , K , Fickert , P , Fuchsbichler , A and Beuers , U . 2005 . Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers . Am J Physiol Gastrointest Liver Physiol , 289 : G88 – G94 .
  • Crowley-Weber , C L , Payne , C M , Gleason-Guzman , M , Watts , G S Futscher , B . 2002 . Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate . Carcinogenesis , 23 : 2063 – 2080 .
  • Earnest , D L , Holubec , H , Wali , R K , Jolley , C S Bissonette , M . 1994 . Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid . Cancer Res , 54 : 5071 – 5074 .
  • Khare , S , Mustafi , R , Cerda , S , Yuan , W Jagadeeswaran , S . 2008 . Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein . Nutr Cancer , 60 : 389 – 400 .
  • Shah , S A , Looby , E , Volkov , Y , Long , A and Kelleher , D . 2005 . Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines . Eur J Cancer , 41 : 2160 – 2169 .
  • Shah , S A , Volkov , Y , Arfin , Q , Abdel-Latif , M M and Kelleher , D . 2006 . Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells . Int J Cancer , 118 : 532 – 539 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.